(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices (Q33912260)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Lockhart B

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Iop F

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Closier M

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lestage P

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

401

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

145-153

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-L-glutamate release from rat hippocampal synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Evidence for a role of presynaptic AMPA receptors in the control of neuronal glutamate release in the rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Cyclothiazide selectively potentiates AMPA- and kainate-induced [3H]norepinephrine release from rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Activation of non-NMDA receptors stimulates acetylcholine and GABA release from dorsal hippocampus: a microdialysis study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Facilitation of glutamate receptors reverses an age-associated memory impairment in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Memory processing by the limbic system: role of specific neurotransmitter systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Regional preferences of AMPA receptor modulators determined through agonist binding autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Facilitation of olfactory learning by a modulator of AMPA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Glutamate in CNS disorders as a target for drug development: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Allosteric potentiation by diazoxide of AMPA receptor currents and synaptic potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Facilitation of glutamate receptors enhances memory

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900433-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2999(00)00433-7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33912260&oldid=1535295682"